Closed-loop insulin delivery: is the holy grail near?

The Lancet

Volumn 375, Issue 9716, 2010, Pages 702-703

  Renard, Eric ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ARTICLE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN TREATMENT; PRIORITY JOURNAL;

EID: 77249118681     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)62165-6     Document Type: Note

References (13)

1. Hovorka R., Allen J.M., Elleri D., et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet (2010) 10.1016/S0140-6736(09)61998-X published online February 5.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
3. Hovorka R., Chassin L.J., Wilinska M.E., et al. Closing the loop: the ADICOL experience. Diabetes Technol Ther 6 (2004) 307-318
4. Hovorka R., Kremen J., Blaha J., et al. Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. J Clin Endocrinol Metab 92 (2007) 2960-2964
5. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet Med 23 (2006) 1-12
6. Steil G.M., Rebrin K., Darwin C., Hariri F., and Saad M.F. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 55 (2006) 3344-3350
7. Renard E., Costalat G., Chevassus H., and Bringer J. Artificial β-cell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab 32 (2006) 497-502
8. Nishida K., Shimoda S., Ichinose K., Araki E., and Shichiri M. What is artificial endocrine pancreas? Mechanism and history. World J Gastroenterol 15 (2009) 4105-4110
9. Steil G.M., Panteleon A.E., and Rebrin K. Closed-loop insulin delivery-the path to physiological glucose control. Adv Drug Deliv Rev 56 (2004) 125-144
10. Renard E., Costalat G., Chevassus H., and Bringer J. Closed loop insulin delivery using implanted insulin pumps and sensors in type 1 diabetic patients. Diabetes Res Clin Pract 74 (2006) S173-S177
11. Renard E., Place J., Cantwell M., Chevassus H., and Palerm C.C. Closed-loop insulin delivery using a subcutaneous glucose sensor and intra-peritoneal insulin delivery: a feasibility study testing a new model for the artificial pancreas. Diabetes Care (2009) 10.2337/dc09-1080 published online Oct 21.
12. Weinzimer S.A., Steil G.M., Swan K.L., Dziura J., Kurtz N., and Tamborlane W.V. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 31 (2008) 934-939
13. Bruttomesso D., Farret A., Costa S., et al. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J Diabetes Sci Technol 3 (2009) 1014-1021